基本药物招标采购评标模型的构建与实证研究——基于模糊群决策法  

Construction and Empirical Study of Evaluation Model for Essential Medicine Bidding and Procurement Based on Fuzzy Group Decision Making

作　　者：黄哲[1] 曹阳[1] 李慧[2] 

机构地区：[1]沈阳药科大学工商管理学院,沈阳110016 [2]哈尔滨工业大学科软股份有限公司,哈尔滨150001

出　　处：《中国药房》2017年第6期721-725,共5页China Pharmacy

基　　金：辽宁省科学技术计划项目(No.2012225095)

摘　　要：目的:建立基本药物招标采购评标模型,提高基本药物招标采购的科学性和有效性。方法:结合基本药物集中招标采购的主要目标,建立基本药物招标采购评标指标体系,采用基于模糊群决策法构建基本药物招标评标模型,并通过实例验证模型的可行性。结果:建立了基于模糊群决策法的基本药物评标模型,并通过阿托代他汀钙片实例分析证明了评标模型的可行性。结论:建立的基于模糊群决策法的基本药物评标模型能够科学、有效地对制药企业进行综合评价,可以促进基本药物招标采购工作公开透明,减轻患者经济负担。OBJECTIVE：To establish the essential medicine bidding evaluation model and improve the scientificity and effectiveness of essential medicine bidding and procurement. METHODS：Combined with the main objective of essential medicine centralized bidding and procurement,a criteria bidding evaluation index system for essential medicine was established,and a bidding evaluation model for essential medicine was built based on fuzzy group decision making and the feasibility was verified by examples. RESULTS：The essential medicine evaluation model based on fuzzy evaluation and group decision making was established,and empirical analysis for Atorvastatin Calcium tablet was used to show the feasibility of evaluation model. CONCLUSIONS：The essential medicine evaluation model based on fuzzy group decision making can scientifically and effectively accomplish a comprehensive evaluation of pharmaceutical enterprises,which builds the foundation for promoting the transparency of essential medicine bidding and procurement work and reducing the economic burden for the patients.

关 键 词：基本药物 招标采购 评标 模糊群决策法 模型 

分 类 号：R95[医药卫生—药学]